Synapse - Jae Park

Search Within

Jae Hong Park

Results (89)

Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia

Meeting Abstract

Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia

Research Letter

Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
Leukemia (2021)

Fulltext@MSK | Save

Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells

Journal Article

Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
Blood Advances (2021)

Fulltext@MSK | Save

Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy

Journal Article

Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
Blood (2021)

Fulltext@MSK | Save

Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
Bone Marrow Transplantation (2021)

Fulltext@MSK | Save

Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
Cytotherapy (2021)

Fulltext@MSK | Save

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia

Journal Article

Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Vemuri, S.; Flynn, J.; Hsu, M.; Devlin, S. M.; Roshal, M.; Gao, Q.; Shukla, M.; more...
Haematologica (2021)

Fulltext@MSK | Save

Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas

Meeting Abstract

Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
Blood (2020)

Fulltext@MSK | Save

Impact of additional cytogenetic abnormalities and complex karyotype on event-free survival in acute promyelocytic leukemia: Analysis from a single academic center plus the APML4 study

Meeting Abstract

Epstein-Peterson, Z. D.; Rajeeve, S.; Derkach, A.; Park, J. H.; Stein, E. M.; Zhang, Y.; Iland, H. J.; Tallman, M. S.
Blood (2020)

Fulltext@MSK | Save

International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells

Meeting Abstract

Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
Bone Marrow Transplantation (2020)

Fulltext@MSK | Save